基于CiteSpace的中医药治疗新型冠状病毒肺炎知识图谱分析  

Analysis of Knowledge Map of TCM Therapy of COVID-19 Based on CiteSpace

作　　者：李思思[1] 杨金月 赵勇[2,3] 华川 左新河 LI Sisi;YANG Jinyue;ZHAO Yong;HUA Chuan;ZUO Xinhe(Hubei University of Chinese Medicine,Wuhan 430061,China;Thyroid Disease Diagnosis and Treatment Center,Hubei Provincial Hospital of TCM;Hubei Provincial Chen’s Inheritance Studio of Goiter Academic School)

机构地区：[1]湖北中医药大学,湖北武汉430061 [2]湖北省中医院甲状腺疾病诊疗中心 [3]湖北省陈氏瘿病学术流派传承工作室

出　　处：《西部中医药》2022年第5期9-12,共4页Western Journal of Traditional Chinese Medicine

基　　金：全国中医学术流派传承工作室第二轮建设项目[国中医药人教函(2019)62号]。

摘　　要：目的:基于CiteSpace软件统计分析中医药治疗新型冠状病毒肺炎(Corona Virus Disease2019,COVID-19)的研究热点、机构合作网络及作者合作网络。方法:检索2020年1月29日至2020年2月29日中国知网(CNKI)收录的中医药治疗COVID-19的相关研究文献,运用CiteSpace V5.6软件对数据进行统计分析并绘制相关图谱。结果:共检索到中医药治疗COVID-19的相关研究文献137篇;目前主要有治未病、瘥后防复、合理用药、中医治疗、中医药、治则治法、诊疗方案等7个研究热点;研究机构共60所,且机构间实现跨区域合作,形成4个主要研究团队。结论:中医药治疗COVID-19有其独特优势,但仍需要进一步深入研究。Objective:To statistically analyze research hot spots,institutional cooperation network and author collaboration network of TCM therapy of COVID-19 based on CiteSpace software.Methods:The related papers about TCM therapy of COVID-19 were searched from CNKI from January 29,2020 to February 29,2020,CiteSpace V5.6 was used to statistically analyze the data and draw the related maps.Results:There were 137papers related to TCM therapy of COVID-19,currently mainly seven research hotspots including preventive treatment of disease,prevention of the recurrence after the recovery,rational medication,TCM therapy,TCM,therapeutic principles and methods,diagnostic and therapeutic regimen,60 research institutions,inter-institutional cooperation has been achieved across the regions,forming four main research teams.Conclusion:TCM has its unique advantage in the treatment of COVID-19,while it needs to be further studied.

关 键 词：新型冠状病毒肺炎 CITESPACE 知识图谱 中医药 

分 类 号：R272[医药卫生—中医儿科学]